CoronaVirus Induced Disease-2019 (COVID-19)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which CoronaVirus Induced Disease-2019 (COVID-19) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (3 shown)

Active — Not RecruitingNot Applicable

NCT05191446

Coronavirus Disease 2019 (Covid-19) Impact on Alcohol-related Liver Disease Patient Outcomes, Care and Alcohol Use

The study consists of a randomized controlled trial evaluating the efficacy and feasibility of a stepped alcohol treatment using telemedicine on unhealthy alcoh…

United States180 participantsStarted 2022-02-01

Treatment: Stepped alcohol intervention (SAT) to reduce unhealthy alcohol use, Usual Care (UC)

CompletedPhase 2

NCT04375397

Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With Severe Acute Respiratory Syndr…

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Lung failure is the main ca…

United States46 participantsStarted 2020-06-06

Treatment: Ibrutinib, Placebo

UnknownPhase 2

NCT04377334

Mesenchymal Stem Cells (MSCs) in Inflammation-Resolution Programs of Coronavirus Disease 2019 (COVID-19) Induced Acute R…

To evaluate the safety, toxicity and immunological effects of infusion of allogeneic bone marrow-derived human mesenchymal stem (stromal) cells (MSCs) and wheth…

Germany40 participantsStarted 2022-05

Treatment: MSC